Judit Horvath
Overview
Explore the profile of Judit Horvath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
1824
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Funke V, Sandmann S, Melcher V, Seggewiss J, Horvath J, Jager N, et al.
Acta Neuropathol Commun
. 2023 Jul;
11(1):124.
PMID: 37501103
To date, several studies on genomic events underlying medulloblastoma (MB) biology have expanded our understanding of this tumour entity and led to its division into four groups-WNT, SHH, group 3...
12.
Reijnders M, Seibt A, Brugger M, Lamers I, Ott T, Klaas O, et al.
Genet Med
. 2023 Apr;
25(7):100838.
PMID: 37057673
Purpose: Mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) regulates cell growth in response to nutritional status. Central to the mTORC1 function is the Rag-GTPase heterodimer. One component of the...
13.
Horvath J, Debreceni Nagy A, Fulop P, Jenei Z
Medicine (Baltimore)
. 2022 Oct;
101(42):e31035.
PMID: 36281113
Introduction: The purpose of our study was to evaluate the effectiveness of low-to moderate intensity aerobic training on cardiorespiratory functions in chronic unconditioned stroke patients. The oxygen uptake efficiency slope...
14.
Dumont M, Weber-Lassalle N, Joly-Beauparlant C, Ernst C, Droit A, Feng B, et al.
Cancers (Basel)
. 2022 Jul;
14(14).
PMID: 35884425
Rare variants in at least 10 genes, including BRCA1, BRCA2, PALB2, ATM, and CHEK2, are associated with increased risk of breast cancer; however, these variants, in combination with common variants...
15.
Rolfes M, Borde J, Mollenhoff K, Kayali M, Ernst C, Gehrig A, et al.
Cancers (Basel)
. 2022 Jul;
14(13).
PMID: 35805063
Male breast cancer (mBC) is associated with a high prevalence of pathogenic variants (PVs) in the BRCA2 gene; however, data regarding other BC predisposition genes are limited. In this retrospective...
16.
Borde J, Laitman Y, Blumcke B, Niederacher D, Weber-Lassalle K, Sutter C, et al.
BMC Cancer
. 2022 Jun;
22(1):706.
PMID: 35761208
Background: Clinical management of women carrying a germline pathogenic variant (PV) in the BRCA1/2 genes demands for accurate age-dependent estimators of breast cancer (BC) risks, which were found to be...
17.
Rhiem K, Auber B, Briest S, Dikow N, Ditsch N, Dragicevic N, et al.
Breast Care (Basel)
. 2022 Jun;
17(2):199-207.
PMID: 35702495
Background: The German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC) has established a multigene panel (TruRisk®) for the analysis of risk genes for familial breast and ovarian cancer. Summary:...
18.
Christensen M, Levy A, Mohammadi N, Niceta M, Kaiyrzhanov R, Dentici M, et al.
Clin Genet
. 2022 May;
102(2):98-109.
PMID: 35616059
Biallelic variants of the gene encoding for the zinc-finger protein 142 (ZNF142) have recently been associated with intellectual disability (ID), speech impairment, seizures, and movement disorders in nine individuals from...
19.
Ranade S, Wieland M, Tam T, Rea J, Horvath J, Hieb A, et al.
Drug Deliv
. 2022 May;
29(1):1326-1334.
PMID: 35499315
The Port Delivery System with ranibizumab (PDS) is an innovative intraocular drug delivery system designed for the continuous delivery of ranibizumab into the vitreous for 6 months and beyond. The...
20.
Kelley R, Tesar D, Wang Y, Agard N, Holder P, Chan J, et al.
Mol Pharm
. 2022 Apr;
19(5):1540-1547.
PMID: 35393854
Treatment of age-related macular degeneration (AMD) with anti-vascular endothelial growth factor (VEGF) biologic agents has been shown to restore and maintain visual acuity for many patients afflicted with wet AMD....